HS code : 3001.20.9000' h' X5 f1 B; k8 D
keywords : Stem Cells, Heart failure, Heart Disease, Bone marrow, Mesenchymal stem cells, Myocardial infarction, Left Ventricular ejection Fraction (LVEF) % Q0 B, z2 b7 F" h5 L- Y9 V! c- R7 g( `3 m, M6 h" q# Q
World’s First Stem Cell Therapy Product “Hearticellgram®-AMI” 4 G4 l- ?- S3 h4 D* l+ q% L7 yPharmicell has successfully developed the world’s first stem cell therapeutics and received NDA approval from the KFDA in July 1, 2011. Hearticellgram-AMI uses autologous stem cells and is a personalized stem cell therapy product which overcomes immune rejection and ethical dilemmas.5 p; u1 z0 c1 v. g2 f1 b
Stem cells can become any type of cells or tissue in the body, just like a parent cell. Stem cells have a multipotent capability that allows them able to divide repeatedly, self-renew, and be differentiated into different types of cells. Thus stem cells can produce certain organs and tissues. Stem cell therapeutics is a therapy that can be used to repair malfunctioning or damaged cells and tissue by injecting autologous adult stem cells when a disease is diagnosed. The effectiveness of stem cell therapeutics has been proved in various incurable diseases such as heart disease, cerebral diseases, and cancer.6 D: s( ~ R9 f: b
$ I* G, D6 L2 u, q3 V# o7 A
http://www.wclassproducts.com/product.jsp?prod_id=228
